Journal of Microbiology Immunology and Infection最新文献

{"title":"Recommendations and guidance for herpes zoster vaccination for adults in Taiwan","authors":"","doi":"10.1016/j.jmii.2024.06.001","DOIUrl":"10.1016/j.jmii.2024.06.001","url":null,"abstract":"<div><p>Herpes zoster (HZ) is a painful, vesicular, cutaneous eruption from reactivation of varicella zoster virus (VZV), which can lead to potentially debilitating complications. The lifetime risk of HZ is estimated to be 20%–30% in the general population, with an increased risk in the elderly and immunocompromised populations. The most effective strategy to prevent HZ and its complications is by vaccination. Two types of HZ vaccines, zoster vaccine live and recombinant zoster vaccine, have been approved for use. This guidance offers recommendations and suggestions for HZ vaccination in adults, aiming to reduce the disease burden of HZ and its complications. It is intended as a guide to first-line healthcare providers, but does not supersede clinical judgement when assessing risk and providing recommendations to individuals. The Working Group on Adult Immunization Practice was appointed by the Infectious Diseases Society of Taiwan (IDST) and recommendations were drafted after a full literature review, using the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. The recommendations were reviewed and revised by expert review panels during a series of consensus meetings and endorsed by the IDST, Taiwan Association of Family Medicine, the Taiwanese Dermatological Association, the Taiwan Oncology Society, the Taiwan Society of Blood and Marrow Transplantation, the Transplantation Society of Taiwan, the Taiwan AIDS Society, and the Taiwan College of Rheumatology. This guidance describes the epidemiology of HZ and provides recommendations for HZ vaccination in adults with varying levels of risk, differing history of previous VZV infection and past varicella or zoster vaccinations.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 5","pages":"Pages 669-684"},"PeriodicalIF":4.5,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224001087/pdfft?md5=1dd4a2238848cb4ff060eace9767d70e&pid=1-s2.0-S1684118224001087-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141528978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk factors and crucial prognostic indicators of mortality in liver transplant recipients with bloodstream infections: A comprehensives study of 1049 consecutive liver transplants over an 11-year period","authors":"","doi":"10.1016/j.jmii.2024.06.002","DOIUrl":"10.1016/j.jmii.2024.06.002","url":null,"abstract":"<div><h3>Background</h3><p>Liver transplantation (LT) is a pivotal treatment for end-stage liver disease. However, bloodstream infections (BSI) in the post-operative period present a significant threat to patient survival. This study aims to identify risk factors for post-LT BSI and crucial prognostic indicators for mortality among affected patients.</p></div><div><h3>Methods</h3><p>We conducted a retrospective study of adults diagnosed with end-stage liver disease who underwent their initial LT between 2010 and 2021. Those who developed BSI post-LT during the same hospital admission were classified into the BSI group.</p></div><div><h3>Results</h3><p>In this cohort of 1049 patients, 89 (8.4%) developed BSI post-LT, while 960 (91.5%) did not contract any infection. Among the BSI cases, 17 (19.1%) patients died. The average time to BSI onset was 48 days, with 46% occurring within the first month post-LT. Of the 123 isolated microorganisms, 97 (78.8%) were gram-negative bacteria. BSI patients had significantly longer stays in the intensive care unit and hospital compared to non-infected patients. The 90-day and in-hospital mortality rates for recipients with BSI were significantly higher than those without infections. Multivariate analysis indicated heightened BSI risk in patients with blood loss &gt;3000 mL during LT (odds ratio [OR] 2.128), re-operation within 30 days (OR 2.341), post-LT bile leakage (OR 3.536), and graft rejection (OR 2.194). Additionally, chronic kidney disease (OR 6.288), each 1000 mL increase in intraoperative blood loss (OR 1.147) significantly raised mortality risk in BSI patients, whereas each 0.1 mg/dL increase in albumin levels correlated with a lower risk of death from BSI (OR 0.810).</p></div><div><h3>Conclusions</h3><p>This study underscores the need for careful monitoring and management in the post-LT period, especially for patients at higher risk of BSI. It also suggests that serum albumin levels could serve as a valuable prognostic indicator for outcomes in LT recipients experiencing BSI.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 5","pages":"Pages 771-781"},"PeriodicalIF":4.5,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224001099/pdfft?md5=6a20aa8cf027293371533deceabf0229&pid=1-s2.0-S1684118224001099-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of ERIC carbapenem-resistant Enterobacteriaceae test, BD Phoenix CPO detect panel, and NG-test CARBA 5 for the detection of main carbapenemase types of carbapenem-resistant Enterobacterales","authors":"","doi":"10.1016/j.jmii.2024.05.013","DOIUrl":"10.1016/j.jmii.2024.05.013","url":null,"abstract":"<div><h3>Background</h3><p>This study aimed to assess the performance of three commercial panels, the ERIC Carbapenem-Resistant Enterobacteriaceae Test (ERIC CRE test), the NG-Test CARBA 5 (NG CARBA 5), and the BD Phoenix CPO Detect Panel (CPO panel), for the detection of main types of carbapenemases among carbapenem-resistant Enterobacterales (CRE).</p></div><div><h3>Methods</h3><p>We collected 502 isolates of carbapenem-resistant Enterobacterales (CRE) demonstrating intermediate or resistant profiles to at least one carbapenem antibiotic (ertapenem, imipenem, meropenem, or doripenem). Carbapenemase genes and their specific types were identified through multiplex PCR and sequencing methods. Subsequently, the ERIC CRE test, CPO panel, and NG CARBA 5 assay were conducted on these isolates, and the results were compared with those obtained from multiplex PCR.</p></div><div><h3>Results</h3><p>The results indicated that the ERIC CRE test exhibited an overall sensitivity and specificity of 98.1% and 93.6%, respectively, which were comparable to 99.1% and 90.6% for the NG CARBA 5. However, the CPO panel demonstrated a sensitivity of only 56.2% in identifying Ambler classes, exhibiting the poorest sensitivity for class A. Moreover, while the ERIC CRE test outperformed the NG CARBA 5 in identifying multi-gene isolates with multiple carbapenemase-encoding genes, the CPO panel failed to accurately classify these isolates.</p></div><div><h3>Conclusions</h3><p>Our findings support the utilization of the ERIC CRE test as one of the methods for detecting carbapenemases in clinical laboratories. Nonetheless, further optimization is imperative for the CPO panel to enhance its accuracy in determining carbapenemase classification and address limitations in detecting multi-gene isolates.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 5","pages":"Pages 782-790"},"PeriodicalIF":4.5,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224001051/pdfft?md5=5d1ed7e8986c84b34ad9e2cdb253d511&pid=1-s2.0-S1684118224001051-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141322128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In vitro induction and selection of fluoroquinolone-resistant mutants in Elizabethkingia anophelis","authors":"","doi":"10.1016/j.jmii.2024.05.011","DOIUrl":"10.1016/j.jmii.2024.05.011","url":null,"abstract":"<div><p>For 29 parent strains, recognized by pulsed-field gel electrophoresis, the MICs multiplied significantly in the ciprofloxacin group than levofloxacin group, following the first and third induction cycle. Ser83Arg in GyrA was the most common site of mutations. No mutation in ParC nor ParE was identified in the selected mutants.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 5","pages":"Pages 822-826"},"PeriodicalIF":4.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224001038/pdfft?md5=ed51460f288d0e41e4e4d091407e06c3&pid=1-s2.0-S1684118224001038-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141275768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan","authors":"Wei-Li Ma ,&nbsp;Wang-Da Liu ,&nbsp;Hsin-Yun Sun ,&nbsp;Wang-Huei Sheng ,&nbsp;Szu-Min Hsieh ,&nbsp;Shang-Ju Wu ,&nbsp;Chien-Ching Hung","doi":"10.1016/j.jmii.2024.04.001","DOIUrl":"10.1016/j.jmii.2024.04.001","url":null,"abstract":"<div><h3>Background</h3><p>The prognosis for people living with HIV (PLWH) who develop lymphomas has been greatly improved by combination antiretroviral therapy (cART) and anti-CD20 monoclonal antibodies. However, real-world clinical data on this patient group in Asia are limited.</p></div><div><h3>Methods</h3><p>Treatment outcomes were retrospectively examined for 104 PLWH with lymphomas between 2000 and 2019. The cohort comprised five PLWH with Hodgkin lymphoma (HL) and 99 with non-Hodgkin lymphomas, including 61 with diffuse large B-cell lymphoma (DLBCL), 19 with Burkitt lymphoma (BL), nine with primary central nervous system lymphoma (PCNSL) and ten with other subtypes.</p></div><div><h3>Results</h3><p>The 5-year overall survival (OS) rates were as follows: HL (100%), PCNSL (76.2%), other subtypes (60.0%), BL (57.4%), and DLBCL (55.6%). Individuals who achieved complete response (CR) to front-line therapies had a significantly better 5-year OS rate than those without (96.2% vs. 17.8%, p &lt; 0.001). PLWH who received cART for ≤6 months had significantly lower CD4+ T-cell counts at lymphoma diagnosis than those who received cART for longer periods (<em>p</em> = 0.048). Additionally, the 5-year OS rate was better for PLWH who received cART for ≤6 months before lymphomas diagnosis than those who received cART for longer periods (64.5% vs. 51.9%, <em>p</em> = 0.114).</p></div><div><h3>Conclusions</h3><p>PLWH with DLBCL or BL had OS rates compatible to patients without HIV infection. Better outcomes for patients achieving CR to front-line therapy and those with shorter cART duration before lymphoma diagnosis suggest an underlying biological distinction in the lymphomas and the involvement of immunity, which warrants further studies.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 426-436"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000707/pdfft?md5=bfcae08a560f15344eea91ee92ffb38d&pid=1-s2.0-S1684118224000707-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140584229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stool microbiota analysis for abundance of genus Klebsiella among adults and children in endemic area for community Klebsiella pneumoniae infection","authors":"Chun-Hsing Liao ,&nbsp;Kai-Liang Kao ,&nbsp;Shu-I Wu ,&nbsp;Chia-Jui Yang","doi":"10.1016/j.jmii.2024.02.001","DOIUrl":"10.1016/j.jmii.2024.02.001","url":null,"abstract":"<div><h3>Background</h3><p>Invasive <em>Klebsiella pneumoniae</em> syndrome is a significant endemic disease in Taiwan. Intestinal colonization of virulent clones that cause this phenomenon has been demonstrated in asymptomatic adults. Comparisons of healthy adults and children with stool <em>K. pneumoniae</em> colonization have rarely been reported. We aimed to evaluate the frequency and abundance of <em>K. pneumoniae</em> in the stool of adults and children by stool microbiota analysis.</p></div><div><h3>Methods</h3><p>Healthy volunteers and their children without antibiotic exposure within 3 months were recruited in a Taiwanese medical center. Stool samples were sent for gut microbiota analysis, using amplification of V3–V4 hypervariable regions of 16sRNA followed by high-throughput sequence. Rectal/stool swabs were sent for <em>K. pneumoniae</em> culture and identification by matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-TOF MS).</p></div><div><h3>Results</h3><p>Fifty-five adults with a mean age of 46.9 years (range, 23.1–72.1 years) and 20 children with a mean age of 2.3 years (range, 0.9–5.8) were enrolled, and 29 adults and 6 children had positive <em>K. pneumoniae</em> swabs. Children had lower microbiota diversity than adults, including higher abundance of phylum <em>Actinobacteria</em> and <em>Proteobacteria</em>, and lower <em>Bacteriodetes</em>. For genus comparison, higher abundance of <em>Escherichia</em>, <em>Streptococcus, Enterococcus</em> and <em>Bifidobacterium</em> were found in children, but the composite abundance of <em>Klebsiella</em> in adults (median: 0.0156, range: 0–0.031) and in children (median: 0.0067, range: 0–0.043) were similar. <em>Klebsiella</em> abundance was significantly higher in participants with positive swabs (p &lt; 0.0001). <em>Klebsiella-</em>positive swabs were strongly negatively correlated with <em>Enterobacter</em> spp. (p &lt; 0.0001), but no known demographic factors correlated with <em>Klebsiella</em>-positive swabs.</p></div><div><h3>Conclusion</h3><p><em>Klebsiella</em> species are present in young children, and the abundance is similar in adults and children. Positive swabs correlate strongly with higher abundance in microbiota analysis.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 470-479"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000380/pdfft?md5=f4fdd732a89b1c5f4c57be5f810f9fb7&pid=1-s2.0-S1684118224000380-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139919382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis","authors":"Huzaifa Ahmad Cheema ,&nbsp;Saleha Abdul Rab ,&nbsp;Momina Butt ,&nbsp;Uzair Jafar ,&nbsp;Abia Shahid ,&nbsp;Aqeeb Ur Rehman ,&nbsp;Ka Yiu Lee ,&nbsp;Syeda Sahra ,&nbsp;Ranjit Sah","doi":"10.1016/j.jmii.2024.03.002","DOIUrl":"10.1016/j.jmii.2024.03.002","url":null,"abstract":"<div><h3>Background</h3><p>The majority of available data on molnupiravir come from an unvaccinated COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence from recent randomized controlled trials (RCTs) as well as observational studies stratified by vaccination status to determine the clinical efficacy and safety of molnupiravir in COVID-19 outpatients.</p></div><div><h3>Methods</h3><p>We searched PubMed, Embase, the Cochrane Library, medRxiv, and ClinicalTrials.gov from inception to November 2023. We conducted our meta-analysis using RevMan 5.4 with risk ratio (RR) as the effect measure.</p></div><div><h3>Results</h3><p>We included 8 RCTs and 5 observational studies in our meta-analysis. Molnupiravir reduced the risk of all-cause mortality (RR 0.28; 95% CI: 0.20–0.79, I² = 0%) but did not decrease the hospitalization rate (RR 0.67; 95% CI: 0.45–1.00, I² = 53%) in the overall population; in the immunized population, no benefits were observed. Molnupiravir lowered the rate of no recovery (RR 0.78; 95% CI: 0.76–0.81, I² = 0%) and increased virological clearance at day 5 (RR 2.68; 95% CI: 1.94–4.22, I² = 85%). There was no increase in the incidence of adverse events.</p></div><div><h3>Conclusions</h3><p>Molnupiravir does not decrease mortality and hospitalization rates in immunized patients with COVID-19. However, it does shorten the disease course and increases the recovery rate. The use of molnupiravir will need to be considered on a case-by-case basis in the context of the prevailing social circumstances, the resource setting, drug costs, and the healthcare burden.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 396-402"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000483/pdfft?md5=4b6955650f5b9b2cd94342d06166bf4f&pid=1-s2.0-S1684118224000483-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140151238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Physical Activity and the incidence of sepsis: A 10-year observational study among 4 million adults","authors":"Kyoung Hwa Lee ,&nbsp;Eun Hwa Lee ,&nbsp;Kyu-na Lee ,&nbsp;Yebin Park ,&nbsp;Young Goo Song ,&nbsp;Kyung Do Han ,&nbsp;Sang Hoon Han","doi":"10.1016/j.jmii.2024.04.009","DOIUrl":"10.1016/j.jmii.2024.04.009","url":null,"abstract":"<div><h3>Background</h3><p>As the group at high risk for sepsis is increasing with the aging of the population, physical activity (PA), which has beneficial effects on various diseases, needs to be considered as a personalized prevention strategy for sepsis without direct anti-sepsis drug.</p></div><div><h3>Purpose</h3><p>To examine the association between the amount of PA (based on intensity, duration, and frequency) and the incidence rates of sepsis and mortality after sepsis.</p></div><div><h3>Methods</h3><p>This was a large-scale, retrospective, longitudinal cohort study using data from the Korean National Health Insurance Service and the biennial general health screening program. The amount of PA self-reported at the time of the health screening was categorized as non-PA, mild (&lt;500 metabolic equivalents [METs]-Min/Week), moderate (500–1000), severe (1000–1500), and extreme (≥1500). The multivariable regression model was adjusted for age, sex, income, body mass index, smoking, alcohol consumption, diabetes, hypertension, dyslipidemia, and chronic diseases.</p></div><div><h3>Results</h3><p>From 4,234,415 individuals who underwent a health screening in 2009, 3,929,165 subjects were selected after exclusion for wash-out period and a 1-year lag period, and then observed for the event of sepsis or all-cause death until December 2020. During a median 10.3 years of follow-up, 83,011 incidents of sepsis were detected. The moderate-PA group showed the lowest incidence (1.56/1000 person-years) and risk for sepsis, with an adjusted hazard ratio (aHR) of 0.73 (95% CI, 0.72–0.75, <em>P</em> &lt; 0.001) compared with the non-PA group. The occurrence of sepsis among people aged ≥65 years and ex-smokers were significantly lower in the moderate-PA group (aHR; 0.77, 95% CI; 0.74–0.79; and 0.68, 0.64–0.71, respectively, <em>P</em>s &lt; 0.001). The long-term all-cause mortality after sepsis was significantly lower in the PA group than in the non-PA group (overall <em>P</em> = 0.003).</p></div><div><h3>Conclusions</h3><p>Physical activity is associated with a lower risk of sepsis, especially in elderly people who have the highest incidence of sepsis. The protective effects of aerobic PA on sepsis might need to be incorporated with other interventions in sepsis guidelines through the accumulation of future studies.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 354-364"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S168411822400077X/pdfft?md5=323572f5921902f73e5598c4686e4ef4&pid=1-s2.0-S168411822400077X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140812139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"ddPCR enables rapid detection of bloodstream infections in patients on home parenteral nutrition: A prospective cohort study","authors":"Veerle E.L.M. Gillis ,&nbsp;Daisy Dalloyaux ,&nbsp;Rene H.M. te Morsche ,&nbsp;Jakko van Ingen ,&nbsp;Özcan Sir ,&nbsp;Chantal P. Rovers ,&nbsp;Yannick Wouters ,&nbsp;Geert J.A. Wanten","doi":"10.1016/j.jmii.2024.03.003","DOIUrl":"10.1016/j.jmii.2024.03.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic intestinal failure patients (CIF) require a central venous access device (CVAD) to administer parenteral nutrition. Most serious complication related to a CVAD is a central line-associated bloodstream infection (CLABSI). The golden standard to diagnose a CLABSI are blood cultures, however, they may require 1–5 days before getting a result. Droplet digital polymerase chain reaction (ddPCR) for the detection of pathogen 16S/28S rRNA is a novel culture-independent molecular technique that has been developed to enhance and expedite infection diagnostics within two and a half hours. In this study, we prospectively compared ddPCR with blood cultures to detect pathogens in whole blood.</p></div><div><h3>Methods</h3><p>We included adult CIF patients with a clinical suspicion of CLABSI in this prospective single-blinded clinical study. Blood cultures were routinely collected and subsequently two central samples from the CVAD and two peripheral samples from a peripheral venous access point. Primary outcome was the sensitivity and specificity of ddPCR.</p></div><div><h3>Results</h3><p>In total, 75 patients with 126 suspected CLABSI episodes were included, with 80 blood samples from the CVAD and 114 from peripheral veins. The central ddPCR samples showed a sensitivity of 91% (95%CI 77–98), and specificity of 96% (95%CI 85–99). Peripheral ddPCR samples had a sensitivity of 63% (95%CI 46–77) and specificity of 99% (95%CI 93–100).</p></div><div><h3>Conclusion</h3><p>ddPCR showed a high sensitivity and specificity relative to blood cultures and enables rapid pathogen detection and characterization. Clinical studies should explore if integrated ddPCR and blood culture outcomes enables a more rapid pathogen guided CLABSI treatment and enhancing patient outcomes.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 375-384"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000495/pdfft?md5=bb494a380ddd49fe7d64903a92774782&pid=1-s2.0-S1684118224000495-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intestinal capillariasis: An indigenous case in Taiwan","authors":"Wei-Te Lee,&nbsp;Chih-Lin Huang,&nbsp;Rong-Jyh Lin,&nbsp;Chao-Ju Chen,&nbsp;Kuan-Li Wu,&nbsp;June-Der Lee,&nbsp;Yue-Chiu Su","doi":"10.1016/j.jmii.2024.04.007","DOIUrl":"10.1016/j.jmii.2024.04.007","url":null,"abstract":"","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 520-522"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000756/pdfft?md5=f4859888ce83d05350bc08e0c1306147&pid=1-s2.0-S1684118224000756-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140765597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}